NovoSci is sponsoring a symposium at an upcoming conference to discuss their Ready System for reduced blood diversion during CABG procedures.
“About 35 percent of CABG (coronary artery bypass grafting) procedures report complications, and the morbidity of CABG is largely attributed to the use of CPB (cardiopulmonary bypass),” said Michael J. Sorna, President and Chief Executive Officer of NovoSci. “We are extremely proud to be sponsoring this symposium, which will demonstrate the effectiveness of ‘mini’ bypass technology as an alternative and less-invasive approach to conventional CPB.”
Bypass procedures totaled 450,000 in 2001 in the U.S., and nearly 85 percent required placing the patient on a ‘heart-lung machine’–i.e., cardiopulmonary bypass, or ‘CPB’–to circulate blood through the body while the heart and lungs are stopped. The main components of the half-a-century-old conventional heart-lung (bypass) machine are numerous, but primarily include a mechanical pump, oxygenator, large cannula and substantial PVC tubing–the total machine is often referred to as simply ‘the pump.’
“The conventional pump can be very stressful for some patients, making survival much more challenging for the sickest,” added Dr. Gregory Trachiotis. “Our ISMICS symposium will look at the mini-pump’s advantages over traditional cardiopulmonary bypass. There are several–which is why we are using the Ready System(R) at DCVAMC. Our symposium will consider the possibility that the mini-pump will replace the conventional form of CPB as the gold standard for most cardiac procedures over time.”
The NovoSci people will talk about the results from the, uh, RESULT trial, at the upcoming meeting of ISMICS (that’s the International Society for Minimally Invasive Cardiothoracic Surgery) in their sponsored symposium.
More at NovoSci…
Flashback: ‘Mini’ Bypass: The Ready System 200
